Consolidated Income Statement | Merck Annual Report 2015

Consolidated Income Statement¹

€ million	Note	2015	2014
Net sales	➞ 8	12,844.7	11,362.8
Cost of sales	➞ 9	– 4,076.3	– 3,526.4
(of which: amortization of intangible assets)²		(– 166.6)	(– 94.0)
Gross profit		8,768.4	7,836.4

Marketing and selling expenses	➞ 10	– 4,049.5	– 3,589.1
(of which: amortization of intangible assets)²		(– 778.9)	(– 719.0)
Administration expenses		– 719.9	– 608.6
Research and development costs	➞ 11	– 1,709.2	– 1,703.7
(of which: amortization of intangible assets)²		(– 2.7)	(– 3.8)
Other operating income	➞ 12	470.7	564.4
Other operating expenses	➞ 13	– 917.3	– 737.4
Operating result (EBIT)		1,843.2	1,762.0

Financial result	➞ 14	– 356.7	– 205.0
Profit before income tax		1,486.5	1,557.0

Income tax	➞ 15	– 368.0	– 392.2
Profit after tax from continuing operations		1,118.5	1,164.8
Profit after tax from discontinued operations		5.6	–
Profit after tax		1,124.1	1,164.8

of which: attributable to Merck KGaA shareholders (net income)		1,114.8	1,157.3
of which: attributable to non-controlling interests	➞ 25	9.3	7.5

Earnings per share (in €)	➞ 16
basic		2.56	2.66
- thereof from continuing operations		2.55	2.66
- thereof from discontinued operations		0.01	–

diluted		2.56	2.66
- thereof from continuing operations		2.55	2.66
- thereof from discontinued operations		0.01	–
¹ The reporting structure has changed, see “Changes to accounting and measurement principles and disclosure changes”. ² Excluding amortization of internally generated or separately acquired software.